These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antihypertensive ergoline derivatives. Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antihypertensive activity of 2,4-dioxoimidazolidin-1-yl and perhydro-2,4-dioxopyrimidin-1-yl ergoline derivatives. Mantegani S; Brambilla E; Caccia C; Chiodini L; Ruggieri D; Lamberti E; Di Salle E; Salvati P Farmaco; 1998 Apr; 53(4):293-304. PubMed ID: 9658588 [TBL] [Abstract][Full Text] [Related]
4. Antiulcer and antisecretory ergoline derivatives. Ruggieri D; Arrigoni C; Di Salle E; Temperilli A; Giudici D Farmaco; 1989 Jan; 44(1):39-50. PubMed ID: 2742720 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of a new antihypertensive agent in several species. Salvati P; Caravaggi AM; Lamberti E; Monteggia M; Bianchi G Arzneimittelforschung; 1983; 33(8):1098-106. PubMed ID: 6685486 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II. Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740 [TBL] [Abstract][Full Text] [Related]
8. Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinones. Barlocco D; Martini A; Pinna GA; Curzu MM; Sala F; Germini M Farmaco Sci; 1987 Aug; 42(8):585-94. PubMed ID: 3666129 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological properties of imidazo-[4,5-b]-pyridine derivatives. Kuczyński L; Mrozikiewicz A; Poreba K Pol J Pharmacol Pharm; 1982; 34(4):229-38. PubMed ID: 7182844 [No Abstract] [Full Text] [Related]
10. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines]. Orallo F; Calleja JM; García Mera G; Raviña E Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551 [No Abstract] [Full Text] [Related]
11. Synthesis and pharmacological study of 4,4a,5,6-tetrahydro-4a-substituted-benzo(h)cinnolin-3(2H)ones. Barlocco D; Pinna GA; Carboni L; Cipolla P Farmaco; 1989 Oct; 44(10):967-74. PubMed ID: 2619862 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of pyrido[1,2-a]pyrimidin-4-ones. Potential antihypertensive agents. III. Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A Farmaco Sci; 1986 Dec; 41(12):926-33. PubMed ID: 3556566 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3. Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of new (5R,8R,10R)-ergoline derivatives with antihypertensive or dopaminergic activity. Ohno S; Adachi Y; Koumori M; Mizukoshi K; Nagasaka M; Ichihara K; Kato E Chem Pharm Bull (Tokyo); 1994 Jul; 42(7):1463-73. PubMed ID: 7923470 [TBL] [Abstract][Full Text] [Related]
15. Derivatives of 1,3,3-trimethyl-6-azabicyclo[3.2.1]octane with hypotensive activity. I. Mariani E; Bondavalli F; Schenone P; Ranise A; Vacca C; Chieppa S; Spadaro R; Marmo E Farmaco Sci; 1983 Sep; 38(9):653-63. PubMed ID: 6641931 [TBL] [Abstract][Full Text] [Related]
16. [Derivatives of 3-hydrazinopyridazine. II. Synthesis and antihypertensive activity of new 3-hydrazino-6-monoalkylaminopyridazines]. Parravicini F; Scarpitta G; Dorigotti L; Pifferi G Farmaco Sci; 1978 Feb; 33(2):99-105. PubMed ID: 631323 [TBL] [Abstract][Full Text] [Related]